Table 1.
Receptor | CD | Effect | Other cell types | Ligand | Tolerancea | Induced/Constitutive |
---|---|---|---|---|---|---|
KIR-L | CD158 | Inh | T, Tγδ, Tm | HLA- I | Yes | C |
CD94/NKG2A | CD159a | Inh | T CD8+, Tγδ | HLA-E | Yes | C |
ILT2 | CD85j | Inh | T, B, Tm | HLA-A, B, C, HLA- G UL18 | ? | C |
KLRG-1 | - | Inh | ILC2, T | Cadherins | Yesb | C |
LAIR-1 | CD305 | Inh | T, B, myeloid | Collagen | Yesb | C |
NKRP1A | CD161 | Inh | T, NKT, ILC | LLT1 | ? | C |
Fc?RIII | CD16 | Act | T, myeloid | IgG-Fc | Yes | C |
KIR-S | CD158 | Act | T, Tγδ, Tm | HLA-I | Yes | C |
NKp30 | CD337 | Act | ILC2, T, Tγδ c | B7H6, BAG6/BAT3 | Yes | C |
NKp44 | CD336 | Act | ILC3, myeloid | MLL5 Nidogen-1 HLA-DP |
? | I |
NKp46 | CD335 | Act | - | Properdin, HA, HN | Yes | C |
NKp65 | - | Act | - | KACL | ? | C |
NKp80 | - | Act | T CD8+, Tγδ | AICL | ? | C |
NKG2D | CD314 | Act | T CD8+, Tγδ | MICA/B, ULBPs | Yes | C |
CD94/NKG2C CD94/NKG2E |
CD159c CD159e |
Act | T CD8+, Tγδ | HLA-E | Yes | C |
2B4 | CD244 | Act/Inhc | T, Tγδ, granulocyte | CD48 | Yes | C |
DNAM-1 | CD226 | Act | T, B, granulocyte | CD112 (Nectin-2), CD155 (PVR) |
No | C |
41BB | CD137 | Act | T, myeloid, endothelial, tumor | CD137L | No | I |
ICOS | CD278 | Act | T | ICOS-L B7RP-1 |
No | I |
OX40 | CD134 | Act | T, NKT granulocyte | OX40-L (CD252) |
No | I |
HA, Hemagglutinin; HN, Hemaglutinin-Neuraminidase; LFA, Lymphocyte function-associated antigen 1; MICA/B, Major histocompatibility complex (MHC) class I chain-related protein A/B; MLL5, Mixed lineage leukemia 5; Tm, Memory T cell; PVR, Poliovirus receptor; ULBP, UL16-binding protein; C, constitutive; I, induced.
Regulation of human NK cell education and/or tolerance.
Role in NK cell tolerance is controversial.
2B4 is an activating receptor in human mature NK cells but an inhibitory receptor in mouse NK cells, human NK cell precursors during NK cell differentiation and in X-linked lymphoproliferative disease (XLP) patients.
? No reported function on NK cell tolerance.